Clinical Trial Update: Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a multi-agent regimen (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin) for Acute Lymphoblastic Leukemia or Lymphobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• PREDNISONE (Prednisone)
• Vincristine sulfate (VINCRISTINE SULFATE)

Snippet

Sponsor: University of Washington | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2022-07-13